<!DOCTYPE html>
<html lang="en">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<meta charset="utf-8">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<title>Summary | Live INTAM Systematic Review</title>
<meta name="author" content="Mohsen Ebrahimi">
<meta name="description" content="Contribution of countries and drug classes  Global contribution to tES/TMS studies for addiction medicine. The number of tES/TMS studies in each country, broken down by the type of addictive...">
<meta name="generator" content="bookdown 0.34 with bs4_book()">
<meta property="og:title" content="Summary | Live INTAM Systematic Review">
<meta property="og:type" content="book">
<meta property="og:url" content="https://mohsenebrahimyir.github.io/intam-sr/summary.html">
<meta property="og:description" content="Contribution of countries and drug classes  Global contribution to tES/TMS studies for addiction medicine. The number of tES/TMS studies in each country, broken down by the type of addictive...">
<meta name="twitter:card" content="summary">
<meta name="twitter:title" content="Summary | Live INTAM Systematic Review">
<meta name="twitter:description" content="Contribution of countries and drug classes  Global contribution to tES/TMS studies for addiction medicine. The number of tES/TMS studies in each country, broken down by the type of addictive...">
<!-- JS --><script src="https://cdnjs.cloudflare.com/ajax/libs/clipboard.js/2.0.6/clipboard.min.js" integrity="sha256-inc5kl9MA1hkeYUt+EC3BhlIgyp/2jDIyBLS6k3UxPI=" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/6.4.6/fuse.js" integrity="sha512-zv6Ywkjyktsohkbp9bb45V6tEMoWhzFzXis+LrMehmJZZSys19Yxf1dopHx7WzIKxr5tK2dVcYmaCk2uqdjF4A==" crossorigin="anonymous"></script><script src="https://kit.fontawesome.com/6ecbd6c532.js" crossorigin="anonymous"></script><script src="libs/jquery-3.6.0/jquery-3.6.0.min.js"></script><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<link href="libs/bootstrap-4.6.0/bootstrap.min.css" rel="stylesheet">
<script src="libs/bootstrap-4.6.0/bootstrap.bundle.min.js"></script><link href="libs/Roboto-0.4.7/font.css" rel="stylesheet">
<script src="libs/bs3compat-0.5.0/transition.js"></script><script src="libs/bs3compat-0.5.0/tabs.js"></script><script src="libs/bs3compat-0.5.0/bs3compat.js"></script><link href="libs/bs4_book-1.0.0/bs4_book.css" rel="stylesheet">
<script src="libs/bs4_book-1.0.0/bs4_book.js"></script><link rel="preconnect" href="https://fonts.googleapis.com">
<link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
<link href="https://fonts.googleapis.com/css2?family=Roboto:wght@300&amp;display=swap" rel="stylesheet">
<script src="https://cdnjs.cloudflare.com/ajax/libs/autocomplete.js/0.38.0/autocomplete.jquery.min.js" integrity="sha512-GU9ayf+66Xx2TmpxqJpliWbT5PiGYxpaG8rfnBEk1LL8l1KGkRShhngwdXK1UgqhAzWpZHSiYPc09/NwDQIGyg==" crossorigin="anonymous"></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/mark.min.js" integrity="sha512-5CYOlHXGh6QpOFA/TeTylKLWfB3ftPsde7AnmhuitiTX4K5SqCLBeKro6sPS8ilsz1Q4NRx3v8Ko2IBiszzdww==" crossorigin="anonymous"></script><!-- CSS --><style type="text/css">
    
    div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  </style>
<link rel="stylesheet" href="stl/style.css">
</head>
<body data-spy="scroll" data-target="#toc">

<div class="container-fluid">
<div class="row">
  <header class="col-sm-12 col-lg-3 sidebar sidebar-book"><a class="sr-only sr-only-focusable" href="#content">Skip to main content</a>

    <div class="d-flex align-items-start justify-content-between">
      <h1>
        <a href="index.html" title="">Live INTAM Systematic Review</a>
      </h1>
      <button class="btn btn-outline-primary d-lg-none ml-2 mt-1" type="button" data-toggle="collapse" data-target="#main-nav" aria-expanded="true" aria-controls="main-nav"><i class="fas fa-bars"></i><span class="sr-only">Show table of contents</span></button>
    </div>

    <div id="main-nav" class="collapse-lg">
      <form role="search">
        <input id="search" class="form-control" type="search" placeholder="Search" aria-label="Search">
</form>

      <nav aria-label="Table of contents"><h2></h2>
        <ul class="book-toc list-unstyled">
<li><a class="" href="index.html">Transcranial brain stimulation for addiction treatment: A live systematic review</a></li>
<li><a class="active" href="summary.html">Summary</a></li>
</ul>

        <div class="book-extra">
          
        </div>
      </nav>
</div>
  </header><main class="col-sm-12 col-md-9 col-lg-7" id="content"><div id="summary" class="section level1 unnumbered">
<h1>Summary<a class="anchor" aria-label="anchor" href="#summary"><i class="fas fa-link"></i></a>
</h1>
<div id="contribution-of-countries-and-drug-classes" class="section level2 unnumbered">
<h2>Contribution of countries and drug classes<a class="anchor" aria-label="anchor" href="#contribution-of-countries-and-drug-classes"><i class="fas fa-link"></i></a>
</h2>
<div class="float">
<img src="fig/figure-2.png" style="width:95.0%" alt="Global contribution to tES/TMS studies for addiction medicine. The number of tES/TMS studies in each country, broken down by the type of addictive substance color coded for the type of intervention; tES in red and TMS in blue. Some of the studies included more than one type of addictive substance in their inclusion criteria. Note that only papers whose full text was in English were included, potentially leading to a relative over-representation of the majority of English-speaking countries. Abbreviation: tES: transcranial electrical stimulation, TMS: transcranial magnetic stimulation."><div class="figcaption">
<strong>Global contribution to tES/TMS studies for addiction medicine.</strong> The number of tES/TMS studies in each country, broken down by the type of addictive substance color coded for the type of intervention; tES in red and TMS in blue. Some of the studies included more than one type of addictive substance in their inclusion criteria. Note that only papers whose full text was in English were included, potentially leading to a relative over-representation of the majority of English-speaking countries. Abbreviation: tES: transcranial electrical stimulation, TMS: transcranial magnetic stimulation.</div>
</div>
<div class="float">
<img src="fig/figure-5.png" style="width:95.0%" alt="tES/TMS studies for addiction treatment across years. The number of tES/TMS studies each year from 2003 till the end of 2022, broken down by the type of addictive substance color-coded by the type of intervention, tES in red and TMS in blue. Some of the studies included more than one type of addictive substance in their inclusion criteria. Abbreviation: tES: transcranial electrical stimulation, TMS: transcranial magnetic stimulation."><div class="figcaption">
<strong>tES/TMS studies for addiction treatment across years.</strong> The number of tES/TMS studies each year from 2003 till the end of 2022, broken down by the type of addictive substance color-coded by the type of intervention, tES in red and TMS in blue. Some of the studies included more than one type of addictive substance in their inclusion criteria. Abbreviation: tES: transcranial electrical stimulation, TMS: transcranial magnetic stimulation.</div>
</div>
</div>
<div id="number-of-subjects-sex-proportion-and-substance-use-disorder-condition" class="section level2 unnumbered">
<h2>Number of subjects, sex proportion, and substance use disorder condition<a class="anchor" aria-label="anchor" href="#number-of-subjects-sex-proportion-and-substance-use-disorder-condition"><i class="fas fa-link"></i></a>
</h2>
<div class="float">
<img src="fig/figure-3.png" style="width:95.0%" alt="Participants in tES/TMS for addiction treatment studies (Total number of subjects in the active stimulation arm = 5519). The Sankey diagram represents the number of participants in FDCR studies divided by gender, the current status of their addiction, type of substances, and interventions. The width of the boxes in each column represents the relative prevalence of each category in the column, while the width of the ribbons connecting the categories across columns represents the proportion of participants shared between each of the two categories. Abbreviation: others are studies that included participants with different types of substance use disorders, tES: transcranial electrical stimulation, TMS: transcranial magnetic stimulation."><div class="figcaption">
<strong>Participants in tES/TMS for addiction treatment studies (Total number of subjects in the active stimulation arm = 5519).</strong> The Sankey diagram represents the number of participants in FDCR studies divided by gender, the current status of their addiction, type of substances, and interventions. The width of the boxes in each column represents the relative prevalence of each category in the column, while the width of the ribbons connecting the categories across columns represents the proportion of participants shared between each of the two categories. Abbreviation: others are studies that included participants with different types of substance use disorders, tES: transcranial electrical stimulation, TMS: transcranial magnetic stimulation.</div>
</div>
</div>
<div id="targeted-brain-areas" class="section level2 unnumbered">
<h2>Targeted brain areas<a class="anchor" aria-label="anchor" href="#targeted-brain-areas"><i class="fas fa-link"></i></a>
</h2>
<div class="float">
<img src="fig/figure-7.png" style="width:95.0%" alt="Stimulation targets for tES/TMS trials for addiction treatment. Stimulation targets based on the type of stimulation are represented over the cortex; Excitatory: HF TMS and anodal tDCS, tACS, Inhibitory: LF TMS, and cathodal tDCS. The depicted number of cortical locations exceeds 198 (the total number of studies in this systematic review) due to the utilization of multiple stimulation protocols in some studies. Notably, in one tDCS study, an HD electrode with anode and cathode placement on the left DLPFC was employed. Bilateral and deep TMS investigations, as well as one temporoparietal stimulation study, for each trial two targets were considered each over a single hemisphere. The term “Frontopolar” collectively refers to the medial prefrontal cortex (mPFC), ventromedial prefrontal cortex (vmPFC), and sMFC regions across the studies. Abbreviations: tES: transcranial electrical stimulation, tDCS: transcranial direct current stimulation, tACS: transcranial alternating stimulation, TMS: transcranial magnetic stimulation, HF TMS: high-frequency TMS (&gt; 5 Hz), LF TMS: low-frequency TMS (&lt; 1 Hz), SFG: superior frontal gyrus, DLPFC: dorsolateral prefrontal cortex, IFG: inferior frontal gyrus, OFC: orbitofrontal cortex, ACC: anterior cingulate cortex, PCC: posterior cingulate cortex, M1: motor cortex."><div class="figcaption">
<strong>Stimulation targets for tES/TMS trials for addiction treatment.</strong> Stimulation targets based on the type of stimulation are represented over the cortex; Excitatory: HF TMS and anodal tDCS, tACS, Inhibitory: LF TMS, and cathodal tDCS. The depicted number of cortical locations exceeds 198 (the total number of studies in this systematic review) due to the utilization of multiple stimulation protocols in some studies. Notably, in one tDCS study, an HD electrode with anode and cathode placement on the left DLPFC was employed. Bilateral and deep TMS investigations, as well as one temporoparietal stimulation study, for each trial two targets were considered each over a single hemisphere. The term “Frontopolar” collectively refers to the medial prefrontal cortex (mPFC), ventromedial prefrontal cortex (vmPFC), and sMFC regions across the studies. Abbreviations: tES: transcranial electrical stimulation, tDCS: transcranial direct current stimulation, tACS: transcranial alternating stimulation, TMS: transcranial magnetic stimulation, HF TMS: high-frequency TMS (&gt; 5 Hz), LF TMS: low-frequency TMS (&lt; 1 Hz), SFG: superior frontal gyrus, DLPFC: dorsolateral prefrontal cortex, IFG: inferior frontal gyrus, OFC: orbitofrontal cortex, ACC: anterior cingulate cortex, PCC: posterior cingulate cortex, M1: motor cortex.</div>
</div>
</div>
<div id="electrodecoil-positioning-system" class="section level2 unnumbered">
<h2>Electrode/coil positioning system<a class="anchor" aria-label="anchor" href="#electrodecoil-positioning-system"><i class="fas fa-link"></i></a>
</h2>
<div class="float">
<img src="fig/figure-8.png" style="width:95.0%" alt="Trial counts for the target of stimulation in TMS/tES studies. Stimulation targets based on the type of stimulation are represented over the cortex; TMS, and tES. The depicted number of cortical locations exceeds 198 (the total number of studies in this systematic review) due to the utilization of multiple stimulation protocols in some studies (for more details see Figure 4). 221 out of 278 trials (79.5%) in 198 published studies targeted left/right DLPFC. Abbreviation: DLPFC: dorsolateral prefrontal cortex, FP: Frontopolar, IFG: inferior frontal gyrus, TP: temporoparietal, ACC: anterior cingulate cortex, OFC: orbitofrontal cortex, M1: motor cortex, SFG: superior frontal gyrus."><div class="figcaption">
<strong>Trial counts for the target of stimulation in TMS/tES studies.</strong> Stimulation targets based on the type of stimulation are represented over the cortex; TMS, and tES. The depicted number of cortical locations exceeds 198 (the total number of studies in this systematic review) due to the utilization of multiple stimulation protocols in some studies (for more details see Figure 4). 221 out of 278 trials (79.5%) in 198 published studies targeted left/right DLPFC. Abbreviation: DLPFC: dorsolateral prefrontal cortex, FP: Frontopolar, IFG: inferior frontal gyrus, TP: temporoparietal, ACC: anterior cingulate cortex, OFC: orbitofrontal cortex, M1: motor cortex, SFG: superior frontal gyrus.</div>
</div>
<div class="float">
<img src="fig/figure-4-a.png" style="width:95.0%" alt="Positioning system in placing tES electrodes or TMS coils over the scalp in tES/TMS for addiction medicine. The Sankey diagram represents the number of tES/TMS studies (n = 198) divided by type of stimulation, type of coil/electrode, and electrode/coil positioning system. Numbers reported in parentheses inside the boxes are the number of studies. Other in stimulation type stands for studies that used a combination of two different stimulation types (e.g., cTBS and iTBS)."><div class="figcaption">
<strong>Positioning system in placing tES electrodes or TMS coils over the scalp in tES/TMS for addiction medicine.</strong> The Sankey diagram represents the number of tES/TMS studies (n = 198) divided by type of stimulation, type of coil/electrode, and electrode/coil positioning system. Numbers reported in parentheses inside the boxes are the number of studies. Other in stimulation type stands for studies that used a combination of two different stimulation types (e.g., cTBS and iTBS).</div>
</div>
<div class="float">
<img src="fig/figure-9-b.png" style="width:95.0%" alt="Positioning system in DLPFC stimulation. 113 out of 223 trials (51.1%) used EEG standard system (F3/F4 location) as the most commonly used method for targeting DLPFC. Other methods are also used for DLPFC stimulation. Abbreviation: tES: transcranial electrical stimulation, TMS: transcranial magnetic stimulation, dTMS: deep TMS, DLPFC: the dorsolateral prefrontal cortex, FP: frontopolar, IFG: inferior frontal gyrus, TP: temporoparietal, ACC: anterior cingulate cortex, M1: motor cortex, PCC: posterior cingulate cortex, SFG, superior frontal gyrus."><div class="figcaption">
<strong>Positioning system in DLPFC stimulation.</strong> 113 out of 223 trials (51.1%) used EEG standard system (F3/F4 location) as the most commonly used method for targeting DLPFC. Other methods are also used for DLPFC stimulation. Abbreviation: tES: transcranial electrical stimulation, TMS: transcranial magnetic stimulation, dTMS: deep TMS, DLPFC: the dorsolateral prefrontal cortex, FP: frontopolar, IFG: inferior frontal gyrus, TP: temporoparietal, ACC: anterior cingulate cortex, M1: motor cortex, PCC: posterior cingulate cortex, SFG, superior frontal gyrus.</div>
</div>
</div>
<div id="outcome-measures" class="section level2 unnumbered">
<h2>Outcome measures<a class="anchor" aria-label="anchor" href="#outcome-measures"><i class="fas fa-link"></i></a>
</h2>
<div class="float">
<img src="fig/figure-1-a.png" style="width:95.0%" alt="Outcome measure in tES/TMS studies for addiction medicine. Different types of outcome measures in tES/TMS studies which, by virtue of their study design, could theoretically support the effectiveness of tES/TMS studies, broken down by substance or intervention of interest and color-coded by the type of intervention; tES in red and TMS in blue. Note that all cells do not sum to 198 since some studies considered more than one outcome measure. Bars show the number of significant (dark lines)/non-significant (light lines) findings based on the results reported in the abstracts. Vertical lines indicate the sig/non-sig results based on the type of stimulation or substance use disorder. Horizontal lines indicate the sig/non-sig results based on the reported outcome measures in the abstract."><div class="figcaption">
<strong>Outcome measure in tES/TMS studies for addiction medicine.</strong> Different types of outcome measures in tES/TMS studies which, by virtue of their study design, could theoretically support the effectiveness of tES/TMS studies, broken down by substance or intervention of interest and color-coded by the type of intervention; tES in red and TMS in blue. Note that all cells do not sum to 198 since some studies considered more than one outcome measure. Bars show the number of significant (dark lines)/non-significant (light lines) findings based on the results reported in the abstracts. Vertical lines indicate the sig/non-sig results based on the type of stimulation or substance use disorder. Horizontal lines indicate the sig/non-sig results based on the reported outcome measures in the abstract.</div>
</div>
</div>
<div id="study-design-and-control-condition" class="section level2" number="0.1">
<h2>
<span class="header-section-number">0.1</span> Study design and control condition<a class="anchor" aria-label="anchor" href="#study-design-and-control-condition"><i class="fas fa-link"></i></a>
</h2>
<div class="float">
<img src="fig/figure-6.png" style="width:95.0%" alt="Study design and control condition. TMS/tES trials in addiction medicine with the type of randomization divided by control condition, color-coded for the type of intervention; tES in red and TMS in blue."><div class="figcaption">
<strong>Study design and control condition.</strong> TMS/tES trials in addiction medicine with the type of randomization divided by control condition, color-coded for the type of intervention; tES in red and TMS in blue.</div>
</div>
</div>
<div id="dosage-number-of-sessions-and-follow-up" class="section level2" number="0.2">
<h2>
<span class="header-section-number">0.2</span> Dosage, number of sessions, and follow up<a class="anchor" aria-label="anchor" href="#dosage-number-of-sessions-and-follow-up"><i class="fas fa-link"></i></a>
</h2>
<div class="float">
<img src="fig/figure-10-a.png" style="width:95.0%" alt="Stimulation dose. Stimulation frequency for TMS is in blue and stimulation intensity for tES studies is in red."><div class="figcaption">
<strong>Stimulation dose.</strong> Stimulation frequency for TMS is in blue and stimulation intensity for tES studies is in red.</div>
</div>
<div class="float">
<img src="fig/figure-10-b.png" style="width:95.0%" alt="Stimulation sessions and follow-up. Follow-up duration breakdown for the number of stimulation sessions for TMS in blue and tES in red."><div class="figcaption">
<strong>Stimulation sessions and follow-up.</strong> Follow-up duration breakdown for the number of stimulation sessions for TMS in blue and tES in red.</div>
</div>

</div>
</div>
  <div class="chapter-nav">
<div class="prev"><a href="index.html">Transcranial brain stimulation for addiction treatment: A live systematic review</a></div>
<div class="empty"></div>
</div></main><div class="col-md-3 col-lg-2 d-none d-md-block sidebar sidebar-chapter">
    <nav id="toc" data-toggle="toc" aria-label="On this page"><h2></h2>
      <ul class="nav navbar-nav">
<li><a class="nav-link" href="#summary">Summary</a></li>
<li><a class="nav-link" href="#contribution-of-countries-and-drug-classes">Contribution of countries and drug classes</a></li>
<li><a class="nav-link" href="#number-of-subjects-sex-proportion-and-substance-use-disorder-condition">Number of subjects, sex proportion, and substance use disorder condition</a></li>
<li><a class="nav-link" href="#targeted-brain-areas">Targeted brain areas</a></li>
<li><a class="nav-link" href="#electrodecoil-positioning-system">Electrode/coil positioning system</a></li>
<li><a class="nav-link" href="#outcome-measures">Outcome measures</a></li>
<li><a class="nav-link" href="#study-design-and-control-condition"><span class="header-section-number">0.1</span> Study design and control condition</a></li>
<li><a class="nav-link" href="#dosage-number-of-sessions-and-follow-up"><span class="header-section-number">0.2</span> Dosage, number of sessions, and follow up</a></li>
</ul>

      <div class="book-extra">
        <ul class="list-unstyled">
          
        </ul>
</div>
    </nav>
</div>

</div>
</div> <!-- .container -->

<footer class="bg-primary text-light mt-5"><div class="container"><div class="row">

  <div class="col-12 col-md-6 mt-3">
    <p>"<strong>Live INTAM Systematic Review</strong>", update date: <strong>2023-01-01</strong></p>
  </div>

  <div class="col-12 col-md-6 mt-3" style="display:none;">
    <p>This page was written by Mohsen Ebrahimi </p>
  </div>

</div></div>
</footer>
</body>
</html>
